SavedAdd your journal

Journals / Journal of Surgery and Medicine / 2020 / Cilt: 4 - Sayı: 6

Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?

C-reaktif protein - albümin oranı akut alt ekstremite iskemisinde amputasyon gelişiminin öngörücüsü olarak kullanılabilir mi?

Burak ERDOLU
Mesut ENGİN
Pages
501–504
Publication Date
2020-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the regression analysis, advanced age (OR: 1.045, CI 95%: 1.004-2.144, P=0.011), CAR (OR: 1.679, CI 95%: 1.224-3.794, P=0.005) and hospital admission time (OR: 1.054, CI 95%: 1.010-1.458, P=0.022) were determined as independent predictors for amputation.Conclusion: The CAR value obtained from routine blood parameters obtained before the procedure may be a good predictor of amputation risk.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Acute lower limb ischemia is a cardiovascular emergency that occurs due to embolic and thrombotic causes.
📊
Key Findings & Data:In this study, we aimed to reveal the predictive value of C reactive protein to albumin ratio (CAR) in predicting limb loss, which is a significantly morbid result of thromboembolectomy.Methods: Patients who were admitted to our clinic with acute lower extremity ischemia between March 15, 2015-March 15, 2018 and who underwent thromboembolectomy were included in this retrospective cohort study.
💡
Conclusion & Impact:In the regression analysis, advanced age (OR: 1.045, CI 95%: 1.004-2.144, P=0.011), CAR (OR: 1.679, CI 95%: 1.224-3.794, P=0.005) and hospital admission time (OR: 1.054, CI 95%: 1.010-1.458, P=0.022) were determined as independent predictors for amputation.Conclusion: The CAR value obtained from routine blood parameters obtained before the procedure may be a good predictor of amputation risk.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Enflamasyon · Amputasyon · Embolektomi

Abstract

Aim: Acute lower limb ischemia is a cardiovascular emergency that occurs due to embolic and thrombotic causes. Inflammatory biomarkers obtained from routine blood parameters have been used in the diagnosis and progression of many cardiovascular diseases. In this study, we aimed to reveal the predictive value of C reactive protein to albumin ratio (CAR) in predicting limb loss, which is a significantly morbid result of thromboembolectomy.Methods: Patients who were admitted to our clinic with acute lower extremity ischemia between March 15, 2015-March 15, 2018 and who underwent thromboembolectomy were included in this retrospective cohort study. The patients in which no extremity amputation was performed after the surgery were included in Group 1 and those in which amputation was performed in the early post-operative period (in-hospital) were included in Group 2. Multivariate logistic regression analysis was utilized to predict parameters supporting amputation in patients with lower extremity thromboembolism.Results: There were 207 patients in Group 1 and 32 in Group 2. Amputation was performed above the knee in 5 patients (15.6%), below the knee in 23 patients (71.8%) and below the ankle in 4 patients (12.5%) in Group 2. The mean age of patients in Groups 1 and 2 were 58.7 (9.8) years and 68.3 (10.3) years, respectively (P<0.001). In the regression analysis, advanced age (OR: 1.045, CI 95%: 1.004-2.144, P=0.011), CAR (OR: 1.679, CI 95%: 1.224-3.794, P=0.005) and hospital admission time (OR: 1.054, CI 95%: 1.010-1.458, P=0.022) were determined as independent predictors for amputation.Conclusion: The CAR value obtained from routine blood parameters obtained before the procedure may be a good predictor of amputation risk.

Özet

Amaç: Akut alt ekstremite iskemisi embolik ve trombotik nedenlerden dolayı ortaya çıkan kardiyovasküler acil bir durumdur. Rutin kan parametrelerinden elde edilen inflamatuar biyobelirteçler birçok kardiyovasküler hastalığın tanısında ve progresyonunda kullanılmıştır. Bu çalışmada, tromboembolektominin önemli bir morbid sonucu olan ekstremite kaybının öngörülmesinde C reaktif proteinin albümin oranının (CAR) prediktif değerini ortaya koymayı amaçladık.Yöntemler: Kliniğimize akut alt ekstremite iskemi durumu olan 15 Mart 2015-15 Mart 2018 tarihleri arasında başvuran ve tromboembolektomi uygulanan hastalar bu retrospektif kohort çalışmasına dahil edildi. Ameliyat sonrası ekstremite amputasyonu yapılmayan hastalar Grup 1, ameliyat sonrası erken dönemde (hasteneiçi) amputasyon yapılan hastalar Grup 2 olarak kaydedildi.Bulgular: Hastaların 207'si Grup 1'e, 32'si Grup 2'ye dahil edildi. 5 hastada (%15,6) diz üstünde, 23 hastada (%71,8) diz altında ve 4 hastada (%12,5) ayak bileği altında amputasyon yapıldı. Grup 1'deki hastaların ortalama yaşı 58,7 (9,8) iken, Grup 2'deki hastalar 68,3 (10,3) idi (P<0,001). Alt ekstremite tromboembolizmi olan hastalarda amputasyonu destekleyen parametreleri tahmin etmek için çok değişkenli lojistik regresyon analizi kullanıldı. Bu değerlendirmede, ileri yaş (OR: 1,045, CI% 95: 1,004-2,144, P=0,011), CAR (OR: 1,679, CI %95: 1,224-3,794, P=0,005) ve hastaneye başvuru zamanı (OR: 1,054, CI %95: 1,010-1,458, P=0,022) amputasyonu göstermek için bağımsız prediktörler olarak belirlendi.Sonuç: Sonuç olarak, işlemden önce alınan rutin kan parametrelerinden elde edilen CAR değeri amputasyon riskinin iyi bir prediktörü olabilir.

🔖

Cite This Article

ERDOLU, B., ENGİN, M. (2020). Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?. Journal of Surgery and Medicine, Cilt: 4 - Sayı: 6, 501–504. https://ajindex.com/articles/780328

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Vemulapalli S, Patel MR, Jones WS. Limb ischemia: cardiovascular diagnosis and management from head to toe. Curr Cardiol Rep. 2015;17:611
  2. Aldağ M, Öztekin A, Bademci MŞ, Kocaaslan C, Denli Yalvaç EŞ, Aydın E. Surgical results of acute thromboembolic limb ischemia in octogenarians. Damar Cer Derg. 2018;27(3):111-6
  3. Akgül E, Engin M, Özyazıcıoğlu AF. Effects of mean platelet volume and platelet counts on peripheral biodegradable stent restenosis. J Surg Med. 2019;3(9):663-5
  4. Kaya BB, Özbilgin N. Effect of cardiac rehabilitation on mortality related inflammatory markers. J Surg Med. 2019;3(8):588-92
  5. Moon AR, Choi DH, Jahng SY, Kim BB, Seo HJ, Kim SH, et al. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for longterm clinical outcomes: a comparable and additive study. Blood Coagul Fibrinolysis. 2016; 271:70–6
  6. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302:49–57
  7. Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018 Jun;52:8-12
  8. Duman H, Cinier G, Bakırcı EM, Duman H, Simsek Z, Hamur H, et al. Relationship between C-reactive protein to albumin ratio and thrombus burden in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2019;25:1076029618824418
  9. Cınar T, Çagdas M, Rencuzogulları I, Karakoyun S, Karabag Y, Yesin M, et al. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019;53:83–90
  10. Ueberrueck T, Marusch F, Schmidt H, Gastinger I. Risk factors and management of arterial emboli of the upper and lower extremities. J Cardiovasc Surg. 2007;48:181–6
  11. Davi G and Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94
  12. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology. 2007;58:513–22
  13. Khera A, De Lemos JA, Peshock RM, Lo HS, Staneg HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113(1):38-43
  14. Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, et al. Inflammation and atherosclerosis—revisited. J Cardiovasc Pharmacol Ther. 2013;19(2):170-8
  15. Bisoendial RJ, Boekholdt